1.HIV detection in Jiading District from 2009 to 2023
ZHANG Yong ; DING Yingying ; ZHONG Peisong ; WANG Weibing ; FENG Yan ; WU Xuefu ; YIN Fanglan
Journal of Preventive Medicine 2024;36(12):1056-1059
Objective:
To analyze the HIV detection results through different detection routes in Jiading District, Shanghai Municipality from 2009 to 2023, so as to provide the reference for improving HIV detection measures.
Methods:
Data pertaining to HIV detection in Jiading District from 2009 to 2023 was collected through the HIV/AIDS Comprehensive Control System of Chinese Disease Prevention and Control Information System. The number of HIV detection and HIV positive rates through detection routes including voluntary counseling and testing (VCT) clinics, sexually transmitted disease (STD) clinics, pre-operation and blood transfusion (products), premarital and antenatal periods, other clinical outpatients and other populations were described.
Results:
A total of 1 729 347 HIV tests were conducted in Jiading District from 2009 to 2023, with an average annual growth rate of 7.55%. A total of 1 125 HIV positive cases were confirmed, with an HIV positive rate of 6.51/104. The number of HIV detection conducted in VCT clinics, STD clinics, pre-operation and blood transfusion (products), premarital and antenatal periods, other clinical outpatients and other populations were 11 516, 112 880, 692 609, 635 770, 196 315 and 80 257, respectively. The main detection routes were pre-operation and blood transfusion (products) as well as premarital and antenatal periods, accounting for 40.05% and 36.76%, respectively. The HIV positive rates in VCT clinics, STD clinics, pre-operation and blood transfusion (products), premarital and antenatal periods, other clinical outpatients and other populations were 336.05/104, 21.79/104, 2.93/104, 0.35/104, 10.95/104 and 6.48/104, respectively. The HIV positive rate in VCT clinics was higher than that in other detection routes (all P<0.001).
Conclusions
From 2009 to 2023, the number of HIV tests increased in Jiading District, mainly through pre-operation and blood transfusion (products) as well as premarital and antenatal periods. The HIV positive rate was the highest in VCT clinics.
2.Association of VKORC1 gene -1639G/A polymorphism with atrial fibrillation in ethnic Uygurs and Hans from Xinjiang.
Peisong WU ; Siqi MENG ; Xianhui ZHOU ; Guojun XU ; Jinxin LI ; Yu ZHANG ; Ling SUN ; Qiang XING ; Shuai SUN ; Hongli WANG ; Qina ZHOU ; Baopeng TANG
Chinese Journal of Medical Genetics 2015;32(2):264-268
OBJECTIVETo assess the association of VKORC1 gene -1639G/A polymorphism with atrial fibrillation (AF) in ethnic Uygurs and Hans from Xinjiang.
METHODSThe above polymorphism was detected among 100 Uygur and 102 Han AF patients and 103 Uygur and 111 Han subjects that have no AF with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
RESULTSA statistically significant difference was detected between the patient and control groups of Uygur origin in terms of genotypic and allelic frequencies (P<0.05). Logistic regression analysis also indicated the -1639G/A polymorphism as an independent risk factor for AF in Uygur population (OR=2.085, 95% CI: 1.067-4.072, P=0.031). No similar statistical difference was found between the patient and control groups of Han origin (P>0.05).
CONCLUSIONThe -1639G/A polymorphism of VKORC1 gene is associated with AF in the Uygur population but not in Hans.
Adult ; Aged ; Asian Continental Ancestry Group ; ethnology ; genetics ; Atrial Fibrillation ; ethnology ; genetics ; Base Sequence ; China ; ethnology ; Female ; Humans ; Male ; Middle Aged ; Molecular Sequence Data ; Polymorphism, Single Nucleotide ; Vitamin K Epoxide Reductases ; genetics
3.Distribution and density of Aedes albopictus in Jiading District of Shanghai in 2020
Qiaoyan WANG ; Shaohua WANG ; Zhengrong WU ; Peisong ZHONG ; Hongxia LIU
Shanghai Journal of Preventive Medicine 2022;34(2):105-108
Objective To determine the seasonal fluctuation and population distribution of
4.Analyzing the Ethical Challenges of Deep Brain Stimulation Technology for Patients, Doctors, and Researchers
Peisong YAN ; Yuyao ZHOU ; Jinsong WU
Chinese Medical Ethics 2023;36(10):1079-1084
Deep brain stimulation (DBS) is an invasive treatment that involves implanting electrodes into the brain to electrically stimulate specific brain regions, bringing new hope for the treatment of motor and psychiatric neurological diseases. This technology is closely related to human consciousness and has sparked heated debates on topics such as consciousness autonomy and personality integrity. Starting from the core principles of protecting patients, this paper explored the controversial issues of consciousness autonomy and medical autonomy principles in DBS practice, and discussed the ethical considerations in informed consent, patient inclusion, information collection, and cutting-edge scientific fields from the perspectives of patients, clinicians, and researchers.